Cadeguomycin, a novel nucleoside analog antibiotic: II. Improved purification, physicochemical properties and structure assignment

49Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Cadeguomycin, a new nucleoside analog antibiotic, has been purified as colorless needle crystals by recycling preparative HPLC. The antibiotic, C12H14O7N4, mp 231~239°C (dec.), FD-MS: m/z 326 (M+); is a weakly acidic substance, showing UV λH2Omax(ε)232 (19677), 272 (6881) and 298 nm (7607), and 1R λKBrmax1650 (C=0) and 3420 (NH or OH) cm-1. The UV spectrum is similar to other pyrrolo[2,3-d]pyrimidines. The structure of cadeguomycin, 2-amino-3,4-dihydro-4-oxo-7-β-D-ribofuranosyI-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylic acid, has been elucidated by 1H NMR and 13C NMR in comparison with other pyrrolo[2,3-d]pyrimidines and their nucleosides. © 1982, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Wu, R. T., Okabe, T., Namikoshi, M., Okuda, S., Nishimura, T., & Tanaka, N. (1982). Cadeguomycin, a novel nucleoside analog antibiotic: II. Improved purification, physicochemical properties and structure assignment. The Journal of Antibiotics, 35(3), 279–284. https://doi.org/10.7164/antibiotics.35.279

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free